Article Details

Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights

Retrieved on: 2022-11-10 03:04:20

Tags for this article:

Click the tags to see associated articles and topics

Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights. View article details on hiswai:

Excerpt

... with CD20-targeted monoclonal antibodies in preclinical models, ... an anti-CD20 monoclonal antibody, in patients with r/r non-Hodgkin ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up